SEC Form 4 · accession 0001061983-16-000037
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert I Blum
Officer — President & CEO · Director
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $6.67 | Feb 23, 2016 | A | 16,506 | A | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 16,506 | 16,506 | D |
| Non-Qualified Stock Option (right to buy)F1 | $6.67 | Feb 23, 2016 | A | 258,494 | A | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 258,494 | 258,494 | D |
Explanation of responses
- F1When the ISO and NQ dated 02/23/2016 are combined for a total grant of 275,000 shares, the option shall vest and become exercisable as to 275,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/23/2020.